George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 31st Mar 2014 10:41

African Minerals: Credit Suisse cuts target price from 280p to 200p maintaining a neutral rating.Anglo American: Credit Suisse reduces target price from 1900p to 1800p and retains an outperform rating.ARM Holdings: Barclays takes target price from 1125p to 1200p and reiterates an overweight recommendation.ASOS: Barclays increases target price from 6000p to 8000p, while its overweight rating remains unchanged.Berendsen: UBS raises target price from 950p to 1100p keeping a neutral rating.Cello Group: N+1 Singer lowers target price from 123p to 122p and retains a buy recommendation.Clinigen Group: Numis takes target price from 620p to 650p upgrading to buy.Daily Mail & General Trust: Westhouse Securities upgrades from neutral to add with a target price of 960p.Darty: N+1 Singer ups target price to 140p and upgrades to buy.easyJet: Numis raises target price from 1900p to 2100p upgrading to buy.Ferrexpo: Barclays shifts target price from 170p to 175p and keeps a neutral rating.Filtronic: Panmure Gordon reduces target price from 84p to 54p downgrading from buy to hold.Glencore Xstrata: Credit Suisse cuts target price from 400p to 380p and retains an outperform rating.Grainger: Jefferies ups target price from 239p to 260p and maintains a buy recommendation.ITE Group: Westhouse Securities cuts target price from 215p to 206p and maintains a neutral rating.Johnson Matthey: UBS raises target price from 3215p to 3275p and reiterates a neutral rating.London Mining: Credit Suisse cuts target price from 170p to 140p leaving its outperform rating unaltered.Majestic Wine: N+1 Singer cuts target price to 470p, while keeping its buy recommendation.Morrison (Wm): Societe Generale cuts target price from 200p to 170p and stays with its sell recommendation.Petards: Northland Capital reinitiates with a target price of 18p and a buy recommendation.Phoenix Group: canaccord Genuity cuts target price from 865p to 800p, while leaving its buy recommendation unchanged.Reckitt Benckiser: Deutsche Bank raises target price from 5100p to 6000p and retains its buy recommendation.Regenersis: Panmure Gordon places both its target price and its buy recommendation under review.Sage Group: Numis raises target price from 383p to 420p, while keeping its hold recommendation.Sainsbury: Societe Generale cuts target price from 370p to 330p reiterating its hold recommendation.Shanks Group: Investec downgrades from buy to add with a target price of 120p.Sportech: Panmure Gordon ups target price from 153p to 184p maintaining a buy recommendation.Travis Perkins: UBS moves target price from 2090p to 2100p and keeps a buy recommendation.Vedanta Resources: Credit Suisse cuts target price from 1270p to 1150p, while staying with its outperform rating.YouGov: Numis ups target price from 109p to 142p maintaining a buy recommendation.Zambeef: Panmure Gordon places both its target price (prev.: 28p) and its sell recommendation under review.
More News
7 Aug 2020 20:11

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

Read more
4 Aug 2020 09:05

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

Read more
1 Jul 2020 12:10

Arsenal Capital makes £179m offer for Cello Health

(Sharecast News) - Cello Health said on Wednesday it had agreed to a takeover from private venture company Arsenal Capital Partners, valuing the company at £179m.

Read more
13 May 2020 16:18

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
8 Apr 2020 12:53

Wednesday broker round-up

(Sharecast News) - Travis Perkins: JP Morgan downgrades to underweight with a target price of 920p.

Read more
7 Apr 2020 12:47

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

Read more
6 Apr 2020 15:17

Access Intelligence Records Widened Annual Loss As Expenses Rise

Access Intelligence Records Widened Annual Loss As Expenses Rise

Read more
18 Mar 2020 14:25

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Read more
11 Mar 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Feb 2020 13:32

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Cello Health To Pay GBP1.6 Million Back To Access Intelligence

Read more
6 Feb 2020 11:21

Cello Health settles with Access Intelligence over Pulsar sale

(Sharecast News) - Healthcare-focussed advisory group Cello Health updated the market on post-completion adjustments in its sale of the Pulsar platform to Access Intelligence on Thursday.

Read more
16 Jan 2020 12:58

Cello Health Reports "Excellent Year" As Restructures Signal Division

Cello Health Reports "Excellent Year" As Restructures Signal Division

Read more
7 Oct 2019 15:23

Cello Health Secures 11% Holding In Access Intelligence

Cello Health Secures 11% Holding In Access Intelligence

Read more
2 Oct 2019 14:15

Cello Health sells Pulsar business to Access Intelligence

(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.

Read more
2 Oct 2019 10:23

Cello Health Sells Social Media Analytics Unit To Access Intelligence

Cello Health Sells Social Media Analytics Unit To Access Intelligence

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.